Streamlined and Standardized Submission Processes for a Japanese Drug Manufacturer's Successful Market Entry into the US Market

A Japan-based pharmaceutical manufacturer sought to enter the US market with multiple products but faced challenges in managing submission complexity, ensuring consistency across dossiers, and meeting stringent FDA timelines. Freyr partnered with the client to standardize publishing and submission processes, enabling efficient dossier preparation, timely submissions, and successful market entry.

Client Overview
Icon

Client Overview

The client is a Japan-based pharmaceutical manufacturer with a growing portfolio of products intended for commercialization in the United States. To support its expansion strategy, the organization required a reliable publishing and submission partner capable of managing large submission volumes while maintaining quality and compliance.

Background Icon

Client Background

As the client expanded into the US market, its existing submission processes lacked standardization and scalability. Variations in submission practices, document formatting, and publishing workflows created inefficiencies and increased the risk of delays. The client needed a structured approach to ensure regulatory compliance while accelerating submission readiness.

Scope Icon

Services in Scope

eCTD publishing and submission support for FDA filings.

Submission planning, validation, and quality review.

Standardization of publishing processes and workflows.

Lifecycle management support for regulatory submissions.

Technical publishing, dossier compilation, and submission readiness assessments.

Challenge
Challenge

Challenges

Challenge

Inconsistent publishing and submission processes across products and teams.

Challenge

High submission volumes requiring efficient resource management and scalability.

Challenge

Need to comply with FDA technical and formatting requirements.

Challenge

Risk of delays due to manual processes and lack of standardized workflows.

Solution

Solution

Freyr implemented a standardized publishing and submission framework designed to improve efficiency, consistency, and regulatory compliance. By establishing robust workflows, quality controls, and submission management processes, Freyr enabled the client to streamline dossier preparation and maintain submission quality across multiple products.

1
Solution Step 1

Assessed existing publishing and submission workflows to identify process gaps and improvement opportunities.

2
Solution Step 2

Established standardized operating procedures, templates, and quality review mechanisms for submission preparation.

3
Solution Step 3

Performed eCTD publishing, technical validation, and dossier compilation in accordance with FDA requirements.

4
Solution Step 4

Managed submission timelines, coordinated stakeholder reviews, and supported lifecycle activities to ensure timely regulatory filings.

5
Solution Step 5

Implemented quality checks and submission readiness reviews to minimize technical rejection risks.

Impact

Impact Metrics

Impact
  • Improved submission consistency through standardized publishing processes and controls.
Impact
  • Enhanced operational efficiency and reduced turnaround times for dossier preparation.
Impact
  • Achieved timely submission delivery while maintaining compliance with FDA technical requirements.
Impact
  • Reduced submission-related risks through robust validation and quality review processes.

 

By transforming fragmented publishing activities into a standardized and scalable submission framework, Freyr enabled the client to successfully support its US market expansion objectives. The streamlined processes improved efficiency, strengthened compliance, and created a sustainable foundation for future regulatory submissions.